We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Novel Surgery Rebuilds Mandible Following Tumor Surgery

By HospiMedica International staff writers
Posted on 01 Nov 2012
A novel surgical approach helps rebuild a functional lower jaw and mouth and preserve the ability to eat and speak after removing an invasive facial tumor, according to a new study.

Researchers at Henry Ford Hospital (Detroit, MI, USA) described a case of a 21-year-old African American male with a history of osteosarcoma that had spread to his lower jawbone three years after the initial diagnosis. More...
The facial tumor soon grew to nearly 4.5 kg of tissue and bone, making it difficult for him to speak and eat, eventually requiring a feeding tube. The patient had previously undergone multiple treatments, including mandible resection, radiation, chemotherapy, and cryosurgery; all treatments were unsuccessful.

The surgeons at Henry Ford Hospital performed a near total mandibulectomy and removal of the tongue and mucous membrane from the inside of both cheeks and lower lip. The complex reconstruction of the face and jaw was then undertaken using dual microvascular free flaps from the left fibula and the subscapular area, a versatile donor system that offers mobility and a diverse range of skin, bone, and muscle available for use in reconstruction of massive facial defects. The study describing the procedure was presented as a poster session at the American Academy of Facial Plastic and Reconstructive Surgery annual meeting, held during September 2102 in Washington DC (USA).

“The bone tumor involved nearly all of his jaw bone, lower lip, chin, neck skin, tongue and both cheeks, approximately the lower third of the face and upper half of his neck,” said senior author and study presenter Tamer Ghanem, MD, PhD., director of the head and neck oncology and microvascular surgery division. “We had to think outside the box to not only safely remove the tumor, but to allow for optimum functional outcome.”

The researcher reported that only three months after the surgery the patient was able to talk and eat without assistance.

Related Links:
Henry Ford Hospital



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.